Home/Hedge Fund Intelligence/Caris Life Sciences, Inc.
Nasdaq: CAIStockForm 13F30 Jun 2026

Hedge funds that hold Caris Life Sciences, Inc. Nasdaq: CAI

CUSIP 142152107 · who reports it, how much, and how much it matters to them

30 of the 720 hedge fund managers we track reported shares of Caris Life Sciences, Inc. (Nasdaq: CAI) on Form 13F for 30 June 2026. Between them they reported USD 626m. The largest position belongs to Coatue Management, at USD 175m. The manager with the most riding on it is Braidwell, where it is 5.4% of the reported book.

Managers reporting it30of 720 we track
Value they reportUSD 626mshares only, 30 Jun 2026
Funds they run450with a file on PPLI.com
Largest positionUSD 175mCoatue Management
Typical weight0.0%median share of a manager's book
Heaviest weight5.4%Braidwell

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

30 managers, USD 626m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Caris Life Sciences, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Coatue Management22 funds on PPLI.comUSD 175m0.4%
2Braidwell12 funds on PPLI.comUSD 147m5.4%
3Pointstate Capital7 funds on PPLI.comUSD 122m1.6%
4Orbimed Advisors1 fund on PPLI.comUSD 50m0.9%
5Millennium Management6 funds on PPLI.comUSD 39m0.0%
6Mak Capital One1 fund on PPLI.comUSD 35m4.8%
7Renaissance Technologies13 funds on PPLI.comUSD 10m0.0%
8Rock Springs Capital Management2 funds on PPLI.comUSD 8.7m0.4%
9Walleye Capital8 funds on PPLI.comUSD 7.6m0.0%
10Squarepoint Ops7 funds on PPLI.comUSD 6.8m0.0%
11Citadel Advisors32 funds on PPLI.comUSD 5.3m0.0%
12Marshall Wace LLP84 funds on PPLI.comUSD 4m0.0%
13D. E. Shaw & Co.15 funds on PPLI.comUSD 3.6m0.0%
14Castleknight Management3 funds on PPLI.comUSD 2.4m0.0%
15Tudor Investment Corporation10 funds on PPLI.comUSD 1.8m0.0%
16Exome Asset Management2 funds on PPLI.comUSD 1.4m0.9%
17Jain Global1 fund on PPLI.comUSD 1.2m0.0%
18Moore Capital Management7 funds on PPLI.comUSD 1.1m0.0%
19Two Sigma Investments35 funds on PPLI.comUSD 640,0000.0%
20Brevan Howard Capital Management39 funds on PPLI.comUSD 621,0000.0%
21Entrypoint Capital1 fund on PPLI.comUSD 601,0000.1%
22Fora Capital1 fund on PPLI.comUSD 403,0000.0%
23Aquatic Capital Management3 funds on PPLI.comUSD 393,0000.0%
24Capstone Investment Advisors25 funds on PPLI.comUSD 360,0000.0%
25Dark Forest Capital Management2 funds on PPLI.comUSD 316,0000.0%
26Scientech Research2 funds on PPLI.comUSD 244,0000.2%
27Hudson Bay Capital Management8 funds on PPLI.comUSD 229,0000.0%
28Magnetar Financial93 funds on PPLI.comUSD 205,0000.0%
29Granville Capital7 funds on PPLI.comUSD 197,0000.1%
30Freestone Grove Partners1 fund on PPLI.comUSD 65,1320.0%
Next: where it matters most
Where it matters most

For Braidwell it is 5.4% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1BraidwellUSD 147m5.4%
2Mak Capital OneUSD 35m4.8%
3Pointstate CapitalUSD 122m1.6%
4Orbimed AdvisorsUSD 50m0.9%
5Exome Asset ManagementUSD 1.4m0.9%
6Rock Springs Capital ManagementUSD 8.7m0.4%
7Coatue ManagementUSD 175m0.4%
8Scientech ResearchUSD 244,0000.2%
9Entrypoint CapitalUSD 601,0000.1%
10Granville CapitalUSD 197,0000.1%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Caris Life Sciences, Inc.

What is the ticker symbol of Caris Life Sciences, Inc.?

Caris Life Sciences, Inc. trades under the symbol CAI on the Nasdaq. Its CUSIP, the code used on Form 13F, is 142152107.

Which hedge funds own Caris Life Sciences, Inc. (Nasdaq: CAI)?

30 of the 720 hedge fund managers PPLI.com tracks reported Caris Life Sciences, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Coatue Management (USD 175m), Braidwell (USD 147m), Pointstate Capital (USD 122m), Orbimed Advisors (USD 50m) and Millennium Management (USD 39m).

How many hedge funds hold Caris Life Sciences, Inc.?

30 managers in our coverage reported it, and between them they run 450 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Caris Life Sciences, Inc.?

Braidwell, where the position was 5.4% of the reported 13F book at 30 June 2026.

Does this show who is short Caris Life Sciences, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Caris Life Sciences, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.